Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GH Guardant Health	$61.28 +4.8%	$49.78	$20.14 ▼ $62.08	$7.64B	1.43	2.40 million shs	2.60 million shs
HIMS Hims & Hers Health	$43.81 +1.0%	$52.18	$13.47 ▼ $72.98	$9.90B	2.08	33.76 million shs	27.60 million shs
PRVA Privia Health Group	$21.33 +0.9%	$20.98	$16.47 ▼ $26.09	$2.62B	0.8	844,729 shs	691,440 shs
RDNT RadNet	$68.61 0.0%	$57.91	$45.00 ▼ $93.65	$5.28B	1.43	829,680 shs	618,989 shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GH Guardant Health	-0.12%	-0.12%	+28.18%	+57.89%	+111.34%
HIMS Hims & Hers Health	+3.08%	-10.06%	-8.78%	-18.86%	+162.85%
PRVA Privia Health Group	-0.28%	+0.62%	+4.91%	-8.44%	+6.76%
RDNT RadNet	+1.05%	+0.36%	+18.47%	+20.91%	+10.27%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GH Guardant Health	3.0924 of 5 stars	1.5	2.0	4.4	2.3	2.5	0.6
HIMS Hims & Hers Health	2.7918 of 5 stars	2.0	3.0	0.0	3.0	3.3	1.9
PRVA Privia Health Group	4.2024 of 5 stars	4.5	3.0	0.0	2.8	2.5	1.9
RDNT RadNet	3.2895 of 5 stars	1.6	2.0	4.6	4.0	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GH Guardant Health	3.06	Buy	$57.50	-6.17% Downside
HIMS Hims & Hers Health	1.92	Reduce	$38.92	-11.16% Downside
PRVA Privia Health Group	2.92	Moderate Buy	$28.00	31.27% Upside
RDNT RadNet	3.25	Buy	$71.60	4.36% Upside

Current Analyst Ratings Breakdown

Latest PRVA, HIMS, GH, and RDNT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2025	HIMS Hims & Hers Health	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2025	PRVA Privia Health Group	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/18/2025	HIMS Hims & Hers Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$48.00 ➝ $37.00
8/18/2025	RDNT RadNet	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2025	RDNT RadNet	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$66.00 ➝ $75.00
8/11/2025	RDNT RadNet	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Overweight
8/11/2025	PRVA Privia Health Group	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$36.00 ➝ $35.00
8/5/2025	HIMS Hims & Hers Health	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/31/2025	GH Guardant Health	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Outperform ➝ Sector Outperform	$57.00 ➝ $60.00
7/31/2025	GH Guardant Health	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$59.00 ➝ $61.00
7/17/2025	HIMS Hims & Hers Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$45.00 ➝ $48.00

(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GH Guardant Health	$739.02M	10.34	N/A	N/A	($2.45) per share	-25.01
HIMS Hims & Hers Health	$1.48B	6.71	$0.37 per share	119.77	$2.49 per share	17.59
PRVA Privia Health Group	$1.74B	1.51	$0.18 per share	117.55	$5.98 per share	3.57
RDNT RadNet	$1.91B	2.77	$3.52 per share	19.50	$15.33 per share	4.48

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GH Guardant Health	-$436.37M	-$3.35	N/A	N/A	N/A	-49.93%	N/A	-28.95%	11/5/2025 (Estimated)
HIMS Hims & Hers Health	$126.04M	$0.80	54.76	84.24	2.85	9.63%	26.26%	13.06%	11/3/2025 (Estimated)
PRVA Privia Health Group	$14.39M	$0.11	193.93	79.00	3.07	0.78%	2.13%	1.25%	11/6/2025 (Estimated)
RDNT RadNet	$2.79M	-$0.20	N/A	129.45	N/A	-0.78%	2.41%	0.82%	N/A

Latest PRVA, HIMS, GH, and RDNT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2025	Q2 2025	RDNT RadNet	$0.17	$0.31	+$0.14	$0.43	$488.06 million	$498.23 million
8/7/2025	Q2 2025	PRVA Privia Health Group	$0.05	$0.02	-$0.03	$0.02	$466.97 million	$521.15 million
8/4/2025	Q2 2025	HIMS Hims & Hers Health	$0.18	$0.17	-$0.01	$0.17	$550.06 million	$544.83 million
7/30/2025	Q2 2025	GH Guardant Health	-$0.52	-$0.44	+$0.08	-$0.80	$211.19 million	$232.09 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
PRVA Privia Health Group	N/A	N/A	N/A	N/A	N/A
RDNT RadNet	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GH Guardant Health	N/A	3.71	3.35
HIMS Hims & Hers Health	1.72	4.98	4.46
PRVA Privia Health Group	N/A	1.65	1.65
RDNT RadNet	0.91	2.00	2.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GH Guardant Health	92.60%
HIMS Hims & Hers Health	63.52%
PRVA Privia Health Group	94.48%
RDNT RadNet	77.90%

Insider Ownership

Company	Insider Ownership
GH Guardant Health	6.10%
HIMS Hims & Hers Health	13.71%
PRVA Privia Health Group	10.70%
RDNT RadNet	5.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GH Guardant Health	2,021	124.71 million	117.10 million	Not Optionable
HIMS Hims & Hers Health	1,637	226.02 million	195.03 million	Optionable
PRVA Privia Health Group	1,140	122.73 million	109.60 million	Optionable
RDNT RadNet	11,021	76.92 million	72.61 million	Optionable

PRVA, HIMS, GH, and RDNT Headlines

Recent News About These Companies

American Century Companies Inc. Acquires 1,063,516 Shares of RadNet, Inc. $RDNT

August 21 at 4:26 AM | marketbeat.com

RadNet, Inc. $RDNT Shares Acquired by LPL Financial LLC

August 21 at 3:08 AM | marketbeat.com

Analyzing Astrana Health (NASDAQ:ASTH) & RadNet (NASDAQ:RDNT)

August 21 at 2:34 AM | americanbankingnews.com

RadNet (NASDAQ:RDNT) Upgraded by Zacks Research to Hold Rating

August 21 at 2:01 AM | americanbankingnews.com

Roubaix Capital LLC Takes $4.27 Million Position in RadNet, Inc. (NASDAQ:RDNT)

August 19 at 6:42 AM | marketbeat.com

551,537 Shares in RadNet, Inc. $RDNT Bought by Nuveen LLC

August 19 at 4:44 AM | marketbeat.com

5 Revealing Analyst Questions From RadNet’s Q2 Earnings Call

August 18 at 6:25 AM | finance.yahoo.com

RadNet: Bloated Capital Base Not Pulling Its Economic Weight (Rating Downgrade)

August 18 at 6:25 AM | seekingalpha.com

Invesco Ltd. Sells 210,244 Shares of RadNet, Inc. (NASDAQ:RDNT)

August 18 at 4:03 AM | marketbeat.com

Connor Clark & Lunn Investment Management Ltd. Decreases Holdings in RadNet, Inc. (NASDAQ:RDNT)

August 18 at 4:03 AM | marketbeat.com

Vanguard Group Inc. Cuts Stake in RadNet, Inc. (NASDAQ:RDNT)

August 18 at 3:26 AM | marketbeat.com

Insider Selling: RadNet, Inc. (NASDAQ:RDNT) EVP Sells 17,000 Shares of Stock

August 17, 2025 | marketbeat.com

Neuberger Berman Group LLC Purchases 58,698 Shares of RadNet, Inc. (NASDAQ:RDNT)

August 17, 2025 | marketbeat.com

RadNet (NASDAQ:RDNT) Stock Rating Upgraded by Wall Street Zen

August 17, 2025 | marketbeat.com

B. Riley Brokers Increase Earnings Estimates for RadNet

August 16, 2025 | marketbeat.com

David Jeffrey Katz Sells 17,000 Shares of RadNet, Inc. (NASDAQ:RDNT) Stock

August 16, 2025 | insidertrades.com

Oak Ridge Investments LLC Acquires Shares of 35,464 RadNet, Inc. (NASDAQ:RDNT)

August 16, 2025 | marketbeat.com

Raymond James Financial Reiterates "Strong-Buy" Rating for RadNet (NASDAQ:RDNT)

August 15, 2025 | marketbeat.com

Public Sector Pension Investment Board Purchases 44,361 Shares of RadNet, Inc. (NASDAQ:RDNT)

August 15, 2025 | marketbeat.com

Citigroup Inc. Raises Position in RadNet, Inc. (NASDAQ:RDNT)

August 15, 2025 | marketbeat.com

Raymond James Financial Reaffirms "Strong-Buy" Rating for RadNet (NASDAQ:RDNT)

August 15, 2025 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PRVA, HIMS, GH, and RDNT Company Descriptions

Guardant Health NASDAQ:GH

$61.28 +2.78 (+4.75%)

Closing price 04:00 PM Eastern

Extended Trading

$62.11 +0.83 (+1.35%)

As of 07:38 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health NYSE:HIMS

$43.81 +0.43 (+0.98%)

Closing price 03:59 PM Eastern

Extended Trading

$43.88 +0.07 (+0.17%)

As of 07:42 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Privia Health Group NASDAQ:PRVA

$21.33 +0.18 (+0.85%)

Closing price 04:00 PM Eastern

Extended Trading

$21.33 0.00 (0.00%)

As of 05:14 PM Eastern

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

RadNet NASDAQ:RDNT

$68.61 -0.03 (-0.04%)

Closing price 04:00 PM Eastern

Extended Trading

$68.60 -0.01 (-0.01%)

As of 04:57 PM Eastern

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time